Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Schreiber, D. Wolf, Matthew Tsai, Jackie Chirinos, V. Deyev, Louis González, T. Malek, R. Levy, E. Podack (2010)
Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation.The Journal of clinical investigation, 120 10
S. Sakaguchi, Tomoyuki Yamaguchi, T. Nomura, M. Ono (2008)
Regulatory T Cells and Immune ToleranceCell, 133
E. Shevach, R. McHugh, C. Piccirillo, A. Thornton (2001)
Control of T‐cell activation by CD4+ CD25+ suppressor T cellsImmunological Reviews, 182
S. Yamazaki, M. Patel, A. Harper, A. Bonito, H. Fukuyama, M. Pack, K. Tarbell, M. Talmor, J. Ravetch, K. Inaba, R. Steinman (2006)
Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction.Proceedings of the National Academy of Sciences of the United States of America, 103 8
L. Bozulic, Y. Wen, Hong-lin Xu, S. Ildstad (2011)
Evidence That FoxP3+ Regulatory T Cells May Play a Role in Promoting Long-Term Acceptance of Composite Tissue AllotransplantsTransplantation, 91
S. Ring, M. Thome, L. Pretsch, A. Enk, K. Mahnke (2007)
Expanded murine regulatory T cells: analysis of phenotype and function in contact hypersensitivity reactions.Journal of immunological methods, 326 1-2
M. Edinger, P. Hoffmann, J. Ermann, Kathryn Drago, C. Fathman, S. Strober, R. Negrin (2003)
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantationNature Medicine, 9
G. Gri, S. Piconese, B. Frossi, Vanessa Manfroi, S. Merluzzi, C. Tripodo, A. Viola, Sandra Odom, J. Rivera, M. Colombo, C. Pucillo (2008)
CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.Immunity, 29 5
P. Hoffmann, Ruediger Eder, L. Kunz-Schughart, R. Andreesen, M. Edinger (2004)
Large scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cellsCancer Cell International, 4
Cynthia Porter, E. Bloom (2005)
Human CD4+CD25+ Regulatory T Cells Suppress Anti‐Porcine Xenogeneic ResponsesAmerican Journal of Transplantation, 5
G. Xia, Malathi Shah, Xunrong Luo (2009)
Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells.Translational research : the journal of laboratory and clinical medicine, 153 2
W. Grossman, J. Verbsky, W. Barchet, M. Colonna, J. Atkinson, T. Ley (2004)
Human T regulatory cells can use the perforin pathway to cause autologous target cell death.Immunity, 21 4
M. Edinger, P. Hoffmann (2011)
Regulatory T cells in stem cell transplantation: strategies and first clinical experiences.Current opinion in immunology, 23 5
Yan Feng (2009)
Regulatory T cells and immune tolerance
K. Siemasko, Jian-ping Gao, V. Calder, R. Hanna, M. Calonge, S. Pflugfelder, J. Niederkorn, M. Stern (2008)
In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.Investigative ophthalmology & visual science, 49 12
Hoffmann (2004)
Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cellsBlood, 104
M. Battaglia, A. Stabilini, M. Roncarolo (2005)
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.Blood, 105 12
S. Papson (1981)
“Model”Humanity & Society, 5
B. Liang, C. Workman, Jan-Mou Lee, C. Chew, B. Dale, Lucrezia Colonna, Marcella Flores, Nianyu Li, E. Schweighoffer, S. Greenberg, V. Tybulewicz, D. Vignali, R. Clynes (2008)
Regulatory T Cells Inhibit Dendritic Cells by Lymphocyte Activation Gene-3 Engagement of MHC Class II
B. Gansuvd, C. Asiedu, Jeanine Goodwin, U. Jargal, L. Deckard, P. Andrades, V. Guarcello, Judith Thomas (2007)
Expansion of CD4+CD25+ suppressive regulatory T cells from rhesus macaque peripheral blood by FN18/antihuman CD28-coated Dynal beads.Human immunology, 68 6
L. Strauss, T. Whiteside, A. Knights, C. Bergmann, A. Knuth, A. Zippelius (2007)
Selective Survival of Naturally Occurring Human CD4+CD25+Foxp3+ Regulatory T Cells Cultured with Rapamycin1The Journal of Immunology, 178
Cynthia Porter, J. Horvath-Arcidiacono, Avneesh Singh, K. Horvath, E. Bloom, M. Mohiuddin (2007)
Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non‐human primate xenotransplantation modelXenotransplantation, 14
David Gondek, Li-Fan Lu, S. Quezada, S. Sakaguchi, R. Noelle (2005)
Cutting Edge: Contact-Mediated Suppression by CD4+CD25+ Regulatory Cells Involves a Granzyme B-Dependent, Perforin-Independent Mechanism1The Journal of Immunology, 174
A. Singh, K. Horvath, M. Mohiuddin (2008)
Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.Transplantation proceedings, 41 1
K. Hippen, Sarah Merkel, D. Schirm, Christine Sieben, D. Sumstad, D. Kadidlo, D. McKenna, J. Bromberg, B. Levine, J. Riley, C. June, P. Scheinberg, D. Douek, Jeffrey Miller, J. Wagner, B. Blazar (2011)
Massive ex Vivo Expansion of Human Natural Regulatory T Cells (Tregs) with Minimal Loss of in Vivo Functional ActivityScience Translational Medicine, 3
S. Yamazaki, T. Iyoda, K. Tarbell, Kara Olson, K. Velinzon, K. Inaba, R. Steinman (2003)
Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic CellsThe Journal of Experimental Medicine, 198
G. Bast (2005)
FOCIS abstract supplementClinical Immunology (Orlando, Fla.), 115
Dong-mei Zhao, A. Thornton, R. DiPaolo, E. Shevach (2006)
Activated CD4+CD25+ T cells selectively kill B lymphocytes.Blood, 107 10
C. Baecher-Allan, Julia Brown, G. Freeman, D. Hafler (2001)
CD4+CD25high Regulatory Cells in Human Peripheral Blood1The Journal of Immunology, 167
Singh AK, Seavey CN, Horvath KA, Mohiuddin MM. Ex‐vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti‐pig T and B cell immune response. Xenotransplantation 2012; 19: 102–111. © 2012 John Wiley & Sons A/S. Abstract: Background: CD4+ CD25+ FoxP3+ regulatory T (Treg) cells play an important role in regulating immune responses. A very small number of Treg cells are present in peripheral blood and lymphoid organs, but due to their ability to suppress the immune response, they have a high potential for immunotherapy in clinics. Successful ex‐vivo expansion of naturally occurring CD4+ CD25+ T cells has been achieved after TCR stimulation in the presence of T cell growth factors. In this study, we evaluated the role of these Treg cells in suppressing proliferative response of baboon T and B cells to pig xenoantigens. Methods: Naturally occurring baboon CD4+ CD25+ regulatory T cells (nTreg) were sorted from peripheral blood and expanded in the presence of either anti‐CD3/CD28 beads or irradiated pig peripheral blood mononuclear cells with IL‐2. Treg cells were also enriched directly from CD4+ T cells cultured in the presence of rapamycin (0.1–10 nm). Mixed lymphocyte culture and polyclonal B cell stimulation with ex‐vivo Treg cells were performed to assess the function of ex‐vivo expanded Treg cells. Results: The nTreg cells were expanded to more than 200‐fold in 4 weeks and retained all the nTreg cell phenotypic characteristics, including high levels of FoxP3 expression. 2‐fold increase in enrichment of CD4+ CD25+ FoxP3+ Treg cells from CD4+ cells was observed with rapamycin compared to cultures without rapamycin. The ex‐vivo expanded Treg cells obtained from both methods were able to suppress the baboon anti‐porcine xenogeneic T and B cell immune response in‐vitro efficiently (more than 90% suppression at 1 : 1 ratio of T regulatory cells: T effector cells), and their suppression potential was retained even at 1 : 256 ratio. However, freshly isolated nTreg cells had only 70% suppression at 1 : 1 ratio, and their suppressive ability was reduced to ≤50% at 1 : 16 ratio. Furthermore, we have found that ex‐vivo expanded Treg can also suppress the proliferation of B cells after polyclonal stimulation. Forty to 50 percent reduction in B cell proliferation was observed when ex‐vivo expanded Treg cells were added to the culture at a 1 : 1 ratio. The addition of CD4+ CD25Neg cells however induced vigorous proliferation. Conclusion: Ex‐vivo expanded CD4+ CD25+ FoxP3+ Treg cells can be used to efficiently suppress xenogeneic immune responses by inhibiting T and B cell proliferation. These ex‐vivo expanded Treg cells may also be used with other immunosuppressive agents to overcome xenograft rejection in preclinical xenotransplantation models.
Xenotransplantation – Wiley
Published: Mar 1, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.